Benzonatate and Roxicet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benzonatate (benzonatate) and Roxicet (acetaminophen; oxycodone hydrochloride). Common drug interactions include nausea among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Benzonatate and Roxicet. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

What is Roxicet?

Roxicet has active ingredients of acetaminophen; oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 2,254 Roxicet users. Check the latest studies of Roxicet.



On Jul, 10, 2026

45 people who take Benzonatate and Roxicet together, and have interactions are studied.

Benzonatate and Roxicet drug interactions.

What are the common drug interactions of Benzonatate and Roxicet, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Osteoporosis (bones weak and more likely to break)
  3. Palpitations (feelings or sensations that your heart is pounding or racing)
  4. Panic reaction
  5. Pneumonia
  6. Rash
  7. Road traffic accident
  8. Suicidal ideation
  9. Tinnitus (a ringing in the ears)
  10. Visual disturbance

male:

  1. Emotional distress
  2. Anxiety
  3. Gynaecomastia (enlargement of the gland tissue of the male breast)
  4. Herpes zoster
  5. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  6. Hot flush (sudden feelings of heat)
  7. Injury
  8. Leukopenia (less number of white blood cells in blood)
  9. Metastatic neoplasm (spreadable cancer tumour)
  10. Nephrolithiasis (calculi in the kidneys)

What are the common drug interactions of Benzonatate and Roxicet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Diabetes mellitus inadequate control
  3. Drug addiction
  4. Renal injury (kidney injury)
  5. Renal tubular necrosis (death of kidney tubules)
  6. Suicide attempt

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Palpitations (feelings or sensations that your heart is pounding or racing)
  3. Panic reaction
  4. Pneumonia
  5. Rash
  6. Road traffic accident
  7. Suicidal ideation
  8. Tinnitus (a ringing in the ears)
  9. Visual disturbance
  10. Vomiting

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Dyspepsia (indigestion)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  7. Asthenia (weakness)
  8. Chest discomfort
  9. Chest pain
  10. Confusional state

60+:

  1. Anxiety
  2. Emotional distress
  3. Herpes zoster
  4. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  5. Hot flush (sudden feelings of heat)
  6. Hypertension (high blood pressure)
  7. Injury
  8. Leukopenia (less number of white blood cells in blood)
  9. Metastatic neoplasm (spreadable cancer tumour)
  10. Nephrolithiasis (calculi in the kidneys)

What are the existing conditions these people have? *

  1. High Blood Pressure: 22 people, 48.89%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 21 people, 46.67%
  3. High Blood Cholesterol: 17 people, 37.78%
  4. Infection: 16 people, 35.56%
  5. Stress And Anxiety: 13 people, 28.89%
  6. Fluid Retention (an abnormal accumulation of fluid in the blood): 13 people, 28.89%
  7. Swelling: 10 people, 22.22%
  8. Osteoporosis (bones weak and more likely to break): 10 people, 22.22%
  9. Inflammation: 10 people, 22.22%
  10. Metastases To Bone (cancer spreads to bone): 9 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and Roxicet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Benzonatate and Roxicet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benzonatate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Roxicet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benzonatate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Roxicet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on benzonatate and acetaminophen; oxycodone hydrochloride (the active ingredients of Benzonatate and Roxicet, respectively), and Benzonatate and Roxicet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: